Cargando…

Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak

Detalles Bibliográficos
Autores principales:	Mahalmani, Vidya, Kumaravel, J., Jain, Manav, Prakash, Ajay, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262419/ https://www.ncbi.nlm.nih.gov/pubmed/34169902 http://dx.doi.org/10.4103/ijp.ijp_430_21

Ejemplares similares

Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Translational research: Bridging the gap between preclinical and clinical research
por: Mahalmani, Vidya, et al.
Publicado: (2022)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Regulatory approval for COVID-19 across the globe
por: Mahalmani, Vidya, et al.
Publicado: (2020)

Emerging antimicrobial resistance and newer tools to address the resistance
por: Goyal, Pardeep Kumar, et al.
Publicado: (2019)

Concept of essential medicines and recent updates
por: Gupta, Shreya, et al.
Publicado: (2023)

Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy
por: Sarma, Phulen, et al.
Publicado: (2018)

COVID-19 pandemic: A review based on current evidence
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

COVID-19: The Unseen Threat for the Healthcare Professionals
por: Sriganesh, Kamath, et al.
Publicado: (2020)

Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review
por: Kumaravel, J., et al.
Publicado: (2023)

Marathon mice: Researcher view on potential roles in preclinical research
por: Kumaravel, J., et al.
Publicado: (2021)

New generation vaccine: Novel approaches of vaccine design and delivery and current challenges of vaccine development
por: Bansal, Seema, et al.
Publicado: (2022)

Imaging techniques in drug development
por: Gupta, Shreya, et al.
Publicado: (2022)

Clinical trials for food – The gray areas: Developing countries' perspective
por: Prabha, Praisy K., et al.
Publicado: (2023)

COVID-19 and the unseen pandemic of child abuse
por: Park, Wesley J, et al.
Publicado: (2022)

Three-dimensional drugs: A new era in the pharmaceutical development
por: Kumar, Harish, et al.
Publicado: (2017)

Intellectual property rights and Indian pharmaceutical industry: Present scenario
por: Prakash, Ajay, et al.
Publicado: (2018)

Drugs in sport: The curse of doping and role of pharmacologist
por: Mahendru, Dhruv, et al.
Publicado: (2019)

Pattern of pharmacological research from the last six decades
por: Joshi, Rupa, et al.
Publicado: (2019)

Artificial intelligence in pharmacovigilance: Practical utility
por: Murali, Kotni, et al.
Publicado: (2019)

Social Pharmacology and its impact on clinics
por: Bansal, Seema, et al.
Publicado: (2021)

Genomic biomarkers: Unveiling the potential for precise cancer therapy response
por: Kaur, Gurjeet, et al.
Publicado: (2023)

Antimicrobial resistance and the growing threat of drug-resistant tuberculosis
por: Pai, Madhukar, et al.
Publicado: (2016)

Connectomics: A pharmacologic viewpoint
por: Harikrishnareddy, Dibbanti, et al.
Publicado: (2018)

Modulation of endocannabinoid system: Success lies in the failures
por: Kumar, Subodh, et al.
Publicado: (2018)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

Antimicrobial resistance and the COVID -19 pandemic: A double threat
por: Kanungo, Reba
Publicado: (2021)

Monkeypox infection: A quick glance
por: Choudhary, Gajendra, et al.
Publicado: (2022)

The Innovation: A Journal to See the Unseen and Change the Unchanged
por: Chen, Ke, et al.
Publicado: (2020)

Brachycephalics: ‘Once a problem is seen it cannot be unseen’
por: Bonnett, Brenda N.
Publicado: (2023)

Antimicrobial Resistance: Addressing a Global Threat to Humanity
por: Walsh, Timothy R., et al.
Publicado: (2023)

Collaborative research in modern era: Need and challenges
por: Bansal, Seema, et al.
Publicado: (2019)

Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19
por: Baker, Edward N.
Publicado: (2020)

Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19
por: Baker, Edward N.
Publicado: (2020)

Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19
por: Baker, Edward N.
Publicado: (2020)

Perfusionists in India: The Unseen COVID-19 Warriors during the Pandemic Crisis
por: R., Manu, et al.
Publicado: (2021)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_biagpfi0i76ci22cncrg11b26b